Use of Eplerenone potential strategy to reduce arterial inflammation among persons with HIV: JAMA
USA: Eplerenone was shown to significantly reduce arterial inflammation in a 12-month, placebo-controlled, randomized clinical trial of 26 well-treated persons with HIV (PWH) without known cardiovascular diseases (CVD). The researchers observed an even greater effect in the most diseased segment of the index vessel. “Mineralocorticoid receptor antagonism by Eplerenone may be a potential strategy to […]